Search
Oruka Therapeutics Inc
ORKAAdd to Watchlist
85.210USD
-8.080-8.66%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.15BMarket Cap
LossP/E TTM
Risk Assessment
Currency: USD Updated: 2026-07-02The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Biotechnology & Medical Research domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for Oruka Therapeutics Inc. The Biotechnology & Medical Research industry's average is 3.36. The company's beta value is -0.23. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Beta vs S&P 500 index
-0.23
VaR
+5.31%
240-Day Maximum Drawdown
+27.99%
240-Day Volatility
+85.08%
Return
Best Daily Return
60 days
+18.03%
120 days
+25.04%
5 years
+147.64%
Worst Daily Return
60 days
-8.66%
120 days
-8.66%
5 years
-17.92%
Sharpe Ratio
60 days
+2.55
120 days
+3.38
5 years
+0.79
Risk Assessment
Maximum Drawdown
240 days
+27.99%
3 years
+77.76%
5 years
+77.76%
Return-to-Drawdown Ratio
240 days
+17.37
3 years
+2.35
5 years
+0.88
Skewness
240 days
+1.35
3 years
+11.48
5 years
+13.75
Volatility
Realised Volatility
240 days
+85.08%
5 years
+78.57%
Standardised True Range
240 days
+3.13%
5 years
+1.46%
Downside Risk-Adjusted Return
120 days
+719.80%
240 days
+719.80%
Maximum Daily Upside Volatility
60 days
+84.05%
Maximum Daily Downside Volatility
60 days
+55.74%
Liquidity
Average Turnover Rate
60 days
+4.91%
120 days
+3.25%
5 years
--
Turnover Deviation
20 days
+89.87%
60 days
+92.35%
120 days
+27.21%